z-logo
open-access-imgOpen Access
New treatments for chronic hepatitis C infection
Author(s) -
Suna Yapalı,
Nurdan Tözün
Publication year - 2016
Publication title -
marmara medical journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.112
H-Index - 11
ISSN - 1309-9469
DOI - 10.5472/mmjsi.2901.09
Subject(s) - medicine , chronic hepatitis , hepatitis c , chronic infection , gastroenterology , virology , immunology , virus , immune system
The goal of HCV treatment is to prevent cirrhosis, hepatocellularcarcinoma, liver-related deaths. The development of direct-actingantiviral (DAA) agents which target various steps in HCV lifecycleled to a revolution by providing nearly complete eradication ofHCV. The new treatment regimens with high cure rates havechanged the standards of care in the regions where patients haveaccess to new treatments. This review addresses the recent updatesin management of chronic hepatitis C infection.Keywords: Hepatitis C, New treatments, Direct antiviral agents

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom